The anticancer activity of caulerpin, caulersin, caulerpenyne and 10,11-epoxycaulerpenyne for colorectal cancer data reveal that caulerpin and caulersin are promising anticancer agents against CRC targets and G6PDH and 6PGD could be important targets for CRC. This evidence concerns the gene H6PD and colorectal carcinoma.